PUBLICATIONS · 37883734
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Jan 1
- First author
- Oesterheld J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- doi: 10.1200/JCO.23.01783
- note
- Source null
- related pmid
- Source null
- relationship
- Comment in
- url
- Source null
Authors and identifiers
- name
- Oesterheld J
- type
- Author
- name
- Ferguson W
- type
- Author
- name
- Kraveka JM
- type
- Author
- name
- Bergendahl G
- type
- Author
- name
- Clinch T
- type
- Author
- name
- Lorenzi E
- type
- Author
- name
- Berry D
- type
- Author
- name
- Wada RK
- type
- Author
- name
- Isakoff MS
- type
- Author
- name
- Eslin DE
- type
- Author
- name
- Brown VI
- type
- Author
- name
- Roberts W
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Oesterheld J
- type
- Author
- name
- Ferguson W
- type
- Author
- name
- Kraveka JM
- type
- Author
- name
- Bergendahl G
- type
- Author
- name
- Clinch T
- type
- Author
- name
- Lorenzi E
- type
- Author
- name
- Berry D
- type
- Author
- name
- Wada RK
- type
- Author
- name
- Isakoff MS
- type
- Author
- name
- Eslin DE
- type
- Author
- name
- Brown VI
- type
- Author
- name
- Roberts W
- type
- Author
- bibliography ids
- nci-bib-58b060b70aa1fb2d23b4c442
- book metadata
- content sha256
- 3d2388d2c6070c08542cc4e3300697fb2a30c8a8324ff5ba22a72527b374d333
- document type
- citation
- dois
- 10.1200/JCO.22.02875
- electronic publication date
- display
- 2023 Oct 26
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37883734
- immutable id
- pubmed:37883734@3d2388d2c6070c08542cc4e3300697fb2a30c8a8324ff5ba22a72527b374d333
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 90-102
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- doi: 10.1200/JCO.23.01783
- note
- Source null
- related pmid
- Source null
- relationship
- Comment in
- url
- Source null
- outcomes validated
- false
- pmid
- 37883734
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- 24ae8026dfa5efd020b17d69ccc441e5eb9584f819b7e85389f5ccb3f0e49ec4
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 Jan 1
- precision
- day
- year
- 2024
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Preserved source evidence · Not medical advice
Triangle